Ethambutol: Friend or foe?

Rosa A. Tang, Jade Schiffman, Roberto Alejandro Cruz, Gabriela Corsi

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

Ethambutol (EMB) is one of the first-line antimycobacterial drugs used to treat tuberculosis and is also used to treat atypical mycobacterium infections. It is almost always used in combination with other antimycobacterial drugs. Ever since the drug's introduction in the 1960s, there have been descriptions of optic neuropathy associated with EMB. Despite a clear association of EMB-induced optic neuropathy, many questions remain unanswered, namely, which tests are more accurate to monitor toxicity, how often should they be performed and once the optic neuropathy is present, how much of it is reversible?

Original languageEnglish (US)
Pages (from-to)59-61
Number of pages3
JournalExpert Review of Ophthalmology
Volume9
Issue number2
DOIs
StatePublished - Jan 1 2014

Keywords

  • Antimycobacterial drugs
  • Ethambutol
  • Ethambutol-induced optic neuropathy
  • Mycobacterium
  • Optic neuropathy

ASJC Scopus subject areas

  • Ophthalmology
  • Biomedical Engineering
  • Optometry

Fingerprint Dive into the research topics of 'Ethambutol: Friend or foe?'. Together they form a unique fingerprint.

Cite this